Tracy Beth Høeg to Lead FDA’s Drug Evaluation Center
Tracy Beth Høeg has been appointed as the new leader of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA). This was confirmed through an official announcement from the agency.
Background on Tracy Beth Høeg
Høeg has served as a key advisor to FDA Commissioner Marty Makary. In her new role, she emphasizes the importance of CDER in safeguarding public health by ensuring that medications are both effective and safe.
Høeg’s Statement
Upon her appointment, Høeg remarked, “This is an incredible opportunity to serve my fellow Americans.” Her commitment to public health and drug safety stands out as a critical aspect of her leadership philosophy.
Leadership Transition at CDER
Høeg’s move to lead CDER comes in the wake of Richard Pazdur’s impending retirement at the end of the month. Pazdur had taken over as CDER Director only a month earlier, at the encouragement of Commissioner Makary.
- Tracy Beth Høeg – new CDER leader
- Richard Pazdur – outgoing CDER Director
- Comes amid a year of significant leadership changes at CDER
Høeg will be the fifth individual to take on this prominent role within the FDA in 2023. This reflects ongoing shifts in leadership at one of the most critical regulatory agencies in the United States.
